Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

11.88p
   
  • Change Today:
      0.025p
  • 52 Week High: 27.75p
  • 52 Week Low: 9.55p
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 177,125
  • Market Cap: £48.98m
  • Beta: 0.01

Latest Deals

Traded Action Notifier PriceAmountValue
08-Aug-25 Transfer To Richard John Rees 0.000p 362,408 £0.00
22-Jul-25 Transfer From Richard John Rees 0.000p 12,858 £0.00
22-Jul-25 Sell Richard John Rees 14.00p 6,429 £900.06
22-Jul-25 Transfer From Craig Jonathan Gulliford 0.000p 12,858 £0.00
22-Jul-25 Sell Craig Jonathan Gulliford 14.00p 6,429 £900.06

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
21-Oct-24 Buy Kevin Crofton 24.00p 2,916,666 £699,999.82
13-Dec-24 Buy Kevin Crofton 17.02p 1,179,000 £200,606.85
30-May-25 Buy Kevin Crofton 15.75p 701,750 £110,525.62
21-Oct-24 Buy Richard John Rees 24.00p 208,333 £49,999.92
24-Oct-24 Sell Richard John Rees 20.00p 174,740 £34,948.00

Director Shareholdings

Notifier Holding Value*
Kevin Crofton 5,447,416 £646,881
Richard John Rees 2,707,555 £321,522
Craig Jonathan Gulliford 1,679,765 £199,472
Ivonne Cantu 125,000 £14,844

Major Shareholders

Notifier** Holding Value*
M&G Investments 49,583,836 £5,888,080
Canaccord Genuity Group Inc 36,167,753 £4,294,921
Baillie Gifford & Co 27,795,238 £3,300,684
Hargreave Hale Limited 22,846,245 £2,712,992
River Global Investors LLP 20,827,081 £2,473,216
AXA Framlington Investment Managers 17,066,645 £2,026,664
Amati Global Investors 15,959,536 £1,895,195
Development Bank of Wales plc 14,376,727 £1,707,236
Finance Wales 14,376,727 £1,707,236
Creo Medical Group EBT 10,000,000 £1,187,500
The Capital Group Companies, Inc. 8,816,807 £1,046,996
Tellworth Investments 5,772,778 £685,517
Hoya Corporation 4,799,880 £569,986
Jonathan Craton 3,400,294 £403,785
Cotterford Co Limited 3,335,398 £396,078
Mark Farmer 3,121,607 £370,691
RBC Trustees (CI) Ltd 2,974,727 £353,249
Angel Co Fund 2,967,120 £352,346

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 11.88p
Change Today 0.025p
% Change 0.21 %
52 Week High 27.75p
52 Week Low 9.55p
Volume 177,125
Shares Issued 412.47m
Market Cap £48.98m
Beta 0.01

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.70% above the market average5.70% above the market average5.70% above the market average5.70% above the market average5.70% above the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Price Trend
76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Income Not Available
Growth
46.91% below the market average46.91% below the market average46.91% below the market average46.91% below the market average46.91% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 23-Sep-2025

Time Volume / Share Price
08:42 42,160 @ 11.85p
08:37 8 @ 11.98p
08:35 417 @ 11.98p
08:35 244 @ 11.75p
08:34 83 @ 11.98p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees
Chair Kevin Crofton

Top of Page